PCYN Stock Chart & Stats
$0.28
$0.00(0.00%)
At close: 4:00 PM EST
$0.28
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.28
Previous CloseN/A
Volume12.36K
Average Volume (3M)905.00
Market Cap
$2.27M
Enterprise Value$1.69M
Total Cash (Recent Filing)$908.82K
Total Debt (Recent Filing)$319.88K
Price to Earnings (P/E)121.7
Beta46286.82
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding8,120,388
10 Day Avg. Volume0
30 Day Avg. Volume905
Financial Highlights & Ratios
PEG Ratio-0.78
Price to Book (P/B)0.66
Price to Sales (P/S)0.23
P/FCF Ratio-3.12
Enterprise Value/Market Cap0.74
Enterprise Value/Revenue0.34
Enterprise Value/Gross Profit0.74
Enterprise Value/Ebitda17.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PCYN FAQ
What was Procyon Corporation’s price range in the past 12 months?
Procyon Corporation lowest stock price was $0.01 and its highest was $0.28 in the past 12 months.
What is Procyon Corporation’s market cap?
Procyon Corporation’s market cap is $2.27M.
When is Procyon Corporation’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Procyon Corporation’s earnings last quarter?
Procyon Corporation released its earnings results on May 15, 2018. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of N/A by $0.01.
Is Procyon Corporation overvalued?
According to Wall Street analysts Procyon Corporation’s price is currently Overvalued.
Does Procyon Corporation pay dividends?
Procyon Corporation does not currently pay dividends.
What is Procyon Corporation’s EPS estimate?
Procyon Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Procyon Corporation have?
Procyon Corporation has 8,120,388 shares outstanding.
What happened to Procyon Corporation’s price movement after its last earnings report?
Procyon Corporation reported an EPS of $0.01 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Procyon Corporation?
Currently, no hedge funds are holding shares in PCYN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Procyon Corporation
Procyon Corporation, along with its affiliated entities, specializes in the development and distribution of proprietary medical solutions. Their primary focus is on addressing various skin conditions, including pressure and stasis ulcers, general wounds, dermatitis, inflammation, and other dermatological issues, predominantly within the United States. The company offers a diverse array of products. Under the AMERIGEL brand, they provide sophisticated skin and wound healing items such as hydrogel dressings, post-operative surgical kits, saline wound rinses, and protective lotions, in addition to hand sanitizer. Their HELIX3 line features Bioactive Collagen products, available in both powder and matrix forms. For comprehensive wound management, the AMERX brand includes various dressing types like calcium alginate, foam, gauze, and hydrocolloid, as well as complete wound care kits containing components like collagen matrix, collagen powder, foam, and hydrogel. Furthermore, Procyon markets compression garments under the EXTREMIT-EASE name. These offerings are distributed through multiple channels: to institutional clients such as hospitals, wound care clinics, nursing homes, home health agencies, and medical practitioners via distributors, and directly to individual consumers through online sales, direct purchases, and independent or chain pharmacies. Founded in 1987, the company's operations are headquartered in Clearwater, Florida.
Technical Analysis
RedHill Biopharma
―
PainReform
―
Universe Pharmaceuticals
―
Akanda Corp
―
Shuttle Pharmaceuticals Holdings, Inc.
―